Crizotinib for ROS1 patients: One small step in biomarker testing, one giant leap for advanced NSCLC patients.

Juan, O; Popat, S

View/Open

Supporting information (63.31Kb)

Date

2017-02

ICR Author

Popat, Sanjay

Marsden,

Author

Juan, O

Popat, S

Type

Journal Article

Subject

Humans

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Pyrazoles

Pyridines

Proto-Oncogene Proteins

Protein Kinase Inhibitors

Neoplasm Staging

Treatment Outcome

Protein-Tyrosine Kinases

Genetic Testing

Molecular Targeted Therapy

Biomarkers, Tumor

Crizotinib

Research team

Thoracic Oncology

Language

eng

Date accepted

2016-11-10

License start date